Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Epidermal keratinocyte differentiation and skin barrier pathways represent the coordinated biological processes responsible for maintaining the skin's integrity and protective function (PMID: 30125317). This program involves the maturation of keratinocytes from the basal layer into corneocytes, characterized by the sequential expression of structural proteins such as filaggrin, loricrin, and involucrin, which form the cornified envelope (PMID: 21833085). Concurrently, the synthesis and secretion of specialized lipids, including ceramides and fatty acids, create the extracellular lamellar matrix essential for preventing transepidermal water loss (StatPearls: Physiology, Skin Barrier). Dysregulation of these pathways is central to the pathogenesis of inflammatory skin diseases like atopic dermatitis and psoriasis, where barrier defects allow for allergen penetration and chronic inflammation (PMID: 25352319). Therapeutic agents like Tapinarof and Vitamin D analogs target these pathways by modulating transcription factors, such as the Aryl hydrocarbon receptor (AhR), that promote the expression of barrier proteins (PMID: 33531143). Understanding these pathways is crucial for developing treatments that go beyond symptom management to restore the skin's fundamental physiological barrier.
Modulation of transcription factors (e.g., AhR, VDR, RAR) and inhibition of barrier-disrupting cytokines (e.g., IL-4, IL-13) to restore structural protein and lipid synthesis.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Epidermal keratinocyte differentiation and skin barrier pathways.